Trinity team’s gene therapy offers promise for treating glaucoma – as well as AMD
Latest advances in X-linked retinitis pigmentosa: Optimizing diagnosis and developments in gene therapy
Formosa Pharmaceuticals makes first shipment of APP13007 to US for commercialization
Advancing the optimal diagnosis & treatment of thyroid eye disease
FDA confirms acceptability of Palatin's remaining Phase 3 pivotal clinical trials for PL9643 in DED
Researchers detail acute angle closure glaucoma attack in patient with Hermansky-Pudlak syndrome
